HLT 490 EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN RESPIRATORY CARE (CASE STUDY)

RUNNING HEAD. EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN
RESPIRATORY CARE 1




HLT-490
EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN RESPIRATORY CARE


Fabian Jolly

Grand Canyon University

HLT-490

,EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN RESPIRATORY CARE 2


TABLE OF CONTENTS




Table of Contents
EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN RESPIRATORY CARE..1
TABLE OF CONTENTS ................................................................................................................ 2
INTRODUCTION .......................................................................................................................... 3
The Importance of Evidence-Based Interventions ...................................................................... 4
The Global Perspective and Future of Cystic Fibrosis Care ....................................................... 5
Healthcare problem ..................................................................................................................... 5
Target patients ............................................................................................................................. 5
Impact of the Issue ...................................................................................................................... 6
PROBLEM OR ISSUE ................................................................................................................... 6
PICO QUESTIONS ...................................................................................................................... 10
LITERATURE REVIEW ..............................................................................................................11
RESEARCH QUESTIONS AND ETHICAL CONSIDERATIONS ............................................ 13
THEORY OR MODEL ................................................................................................................. 16
IMPLEMENTATION PLAN ........................................................................................................ 18
EVALUATION PLAN .................................................................................................................. 19
DISSEMINATION PLAN ............................................................................................................ 22
CONCLUSION/SUMMARY ....................................................................................................... 24
Key Project Highlights .............................................................................................................. 24
The primary discoveries and suggestions are as follows .......................................................... 25
The Way Ahead ............................................................................................................................... 26

, EVIDENCE-BASED INTERVENTION FOR CYSTIC FIBROSIS IN RESPIRATORY CARE 3


INTRODUCTION
Cystic Fibrosis (CF) is a multifaceted hereditary condition that predominantly impacts

the respiratory and gastrointestinal systems. The condition is distinguished by the buildup of

viscous and adhesive mucus in multiple organs, primarily the lungs, resulting in persistent

respiratory infections, inflammation, and gradual deterioration of lung function. Over the course

of time, notable progressions in medical expertise and technological advancements have resulted

in enhanced comprehension of cystic fibrosis (CF) pathophysiology and the formulation of

interventions grounded in empirical evidence, with the objective of enhancing the well-being and

lifespan of individuals affected by CF. The primary objective of this capstone project is to

investigate and execute evidence-based interventions for individuals diagnosed with cystic

fibrosis (CF) in the context of respiratory care.

Congestive heart failure (CF) continues to pose significant challenges in terms of its

management, primarily due to the variability in its clinical presentation and the progressive

nature of the disease. The respiratory bacteriology of individuals with cystic fibrosis (CF) has

been subject to alterations, as indicated by the European Cystic Fibrosis Society (ECFS) patient

registry. Consequently, there is a need for ongoing adaptation of treatment approaches

(Hatziagorou et al., 2020). In order to effectively manage CF-related lung disease, it is

imperative to adopt a comprehensive approach to care, especially for individuals who are in the

advanced stages of CF lung disease. This is because timely and appropriate interventions play a

crucial role in preserving respiratory function and promoting overall health and wellness

(Kapnadak et al., 2020).